AIDS TREATMENT NEWS No. 052 - March 11, 1988
John S. James
A typographical error in the October 1987 AmFAR Directory of Experimental Treatments for AIDS and ARC caused the recommended dose of naltrexone to be listed erroneously as "1.75 mg/kg". The intended dose was 1.75 mg per day. The erroneous dose was over 50 times too large and is potentially harmful.
A photocopy of the section containing the error also went out (together with correct information) with material from Project Inform.
Meanwhile Bernard Bihari M.D., the developer of the naltrexone AIDS/ARC treatment, has increased the recommended dose from 1.75 mg per day to 2.75 mg per day.
For complete instructions including all the corrections, contact Project Inform, (800) 822-7422 from outside of California, (800) 334-7422 from within California, or (415) 928-0293 from anywhere.
* Pharmacy Price List Available
David J. Flores of San Francisco checked prices of drugs commonly used by persons with AIDS or ARC, at five different pharmacies in San Francisco. Prices usually varied by about 20 percent, in a few cases much more. The drugs included AZT, Acyclovir, Mycelex, Mycolog II, Halcion, Septra DS, Ketaconazole, Ativan, Trimethoprim, Dapsone, and Atarax; prices were for equivalent generics when available. Persons near San Francisco can use the list directly; persons elsewhere can check the price ranges to see if they are paying too much. We commend Mr. Flores for the public service of putting this list together.
To obtain a copy, send a self-addressed stamped envelope to: David J. Flores, 724 Kansas St., San Francisco, CA 94107.
880311
ATN05205
Copyright © 1988 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .